Comparing the Efficacy and Safety of Fremanezumab for Chronic Cluster Headache

Study Title
A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)
Teva Identifier
TV48125-CNS-30057 | 2016-003171-21
ClinicalTrials.gov Identifier
NCT02964338
Study Status
Terminated
Trial Condition(s)
Chronic Cluster Headache
Interventions
Drug: Fremanezumab | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 70 Years
Trial Duration
January 17, 2017 - July 18, 2018
Phase
Phase 3

Study Type

Interventional